Stocks
Intercept Pharmaceuticals (ICPT) EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -278.7 | -294.6 | -212.2 | -34.9 | -61.7 | -35.0 | ||
| Changes by years, y/y, % | -16% | +6% | -28% | -84% | +77% | -28.5% | |||
Intercept Pharmaceuticals. EBITDA US GAAP, bln rub
Intercept Pharmaceuticals. EBITDA US GAAP, changes, %
Intercept Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Intercept Pharmaceuticals (ICPT) EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -7.65 | -14.7 | -26.5 | 1.09 | 5.15 | -35.0 | |
| Changes by years, y/y, % | -172% | -30% | +151% | -108% | -167% | |||
| Changes by quarters, q/q, % | -47% | +93% | +80% | -104% | +372% | |||
